Back
Penumbra, Inc.

Penumbra, Inc.

PEN

Loading Stocks

$255.95

$5.02 (-1.92%)

1D

1W

3M

1Y

5Y

ALL

Overview

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Open

$256.94

Prior close

$260.97

Today's high

$257.78

Today's low

$250.11

52 Week high

$310.00

52 Week low

$148.00
News
ITGR or PEN: Which Is the Better Value Stock Right Now?
Newsfeed image icon
Zacks Industry Outlook Penumbra, Integer and AngioDynamics
Newsfeed image icon
PEN Stock Rises Following the Launch of Ruby XL System
Newsfeed image icon
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
Newsfeed image icon
View disclosures

Start Your Investing Journey At MoneyLion

Access fully managed portfolios to help you invest towards your future, without the heavy lifting.

Market Data

Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.